Margaret J. Uprichard

Nessuna posizione attualmente

65 anni

Health Technology

Consumer Services

Profilo

Dr. Uprichard joined in January 2003 as Vice President, Clinical and Regulatory Affairs.
In December 2003, she was promoted to Senior Vice President, Clinical and Regulatory Affairs and in December 2004 to Senior Vice President, Drug Development to more reflect her responsibilities within Point.
Prior to joining, she founded a consulting company in drug development and served as Head of Regulatory, Clinical and/or Preclinical Affairs for both Curis, Inc and Paion, GmbH, from 2001-2003.
From 1990-2001, Dr. Uprichard held senior positions in both Clinical and Regulatory Affairs for Warner-Lambert/Pfizer in the oncology, neurology, cardiovascular, and rheumatology areas.

Precedenti posizioni note di Margaret J. Uprichard

Società	Posizione	Fine
EPIX Pharmaceuticals, Inc. EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA.	Consigliere Generale	29/05/2008
Point Therapeutics, Inc. Point Therapeutics, Inc. BiotechnologyHealth Technology Point Therapeutics, Inc. develops drugs for the treatment of cancer and blood cell disorders. The company's PT-100 (talabostat) treats anemia and neutropenia (low levels of white blood cells), which can be caused by diseases or medical treatments, such as chemotherapy. The drugs stimulate production of proteins that build up the body's immune system against malignant tumors. Point Therapeutics, Inc. is located in Boston, MA.	Direttore Tecnico/Scientifico/R&S	26/03/2007

Vedi nel dettaglio l'esperienza di Margaret J. Uprichard

Formazione di Margaret J. Uprichard

University of Michigan

Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private